Companies / Dbv Technologies S.A.

Dbv Technologies S.A.

Nasdaq: DBVTCIK 1613780CHATILLONdbv-technologies.com โ†—

Financials ยท FY2025

Revenue$5.64M
Net income$-146.95M
Total debt$510.0K
Cash$174.90M
Diluted EPS$-1.05
Shares outstanding296.1M

Ownership

296.1M shares outstanding ยท as of Jul 16, 2026
1.1%10%+ / strategic
Ownership
10%+ / strategic1.12%3,309,055
Institutions4.65%13,778,624
Public float94.23%278,973,818

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider% of sharesShares
667, L.P.FormerDirector
โ€”โ€”
โ€”โ€”
โ€”โ€”
โ€”โ€”
Baker FelixFormerDirector
โ€”โ€”
Baker JulianFormerDirector
โ€”โ€”
Mohideen PharisChief Medical Officer
โ€”โ€”

Institutional holders 59

View all โ†’

Activity

Jun 30, 2026View all โ†’
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ฮ”Position afterImpact
Q1 2026
as of
Perceptive Advisors LLC
13F manager
NewADR$20.15M+964K
964,391
0.33% of shares
medium
Q1 2026
as of
Millennium Management LLC
13F manager
TrimADR$-6.73M-322K
-50.23%
318,959
0.11% of shares
medium
Q1 2026
as of
Dorsey Wright & Associates
13F manager
NewADR$2.14M+103K
102,550
0.03% of shares
low
Q2 2026
as of
Deutsche Bank AG
13F manager
NewADR$971.5K+59K
59,240
0.02% of shares
low
Q2 2026
as of
LPL Financial LLC
13F manager
NewADR$881.5K+54K
53,751
0.02% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
ExitADR$-650.8K-34K
-100.00%
0
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
ExitADR$-401.8K-21K
-100.00%
0
low
Q1 2026
as of
HighVista Strategies LLC
13F manager
ExitADR$-304.4K-16K
-100.00%
0
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Janus Henderson Group PLCPassive13G/Aโ€”โ€”โ€”
Citadel Advisors LLCPassive13G/Aโ€”โ€”โ€”
Artisan Partners Asset Management Inc.Passive13Gโ€”3,309,055โ€”
Venrock Healthcare Capital Partners II, L.P.Passive13G/Aโ€”โ€”โ€”
Vivo Opportunity Fund Holdings, L.P.Passive13G/Aโ€”โ€”โ€”
Invus, L.P.Passive13G/Aโ€”โ€”โ€”
MPM BioImpact LLCPassive13Gโ€”โ€”โ€”

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DBVTADREquity23306J309BBG0076D3T39